We developed a ceRNA network (LINC01122 -hsa-miR-34c-5p/hsa-miR-449a-TPD52 ceRNA) network related to the prognosis of PRAD, which is superior for understanding the relationship between lncRNA, miRNA, and mRNA. The gene discussed is TPD52; the disease is prostate adenocarcinoma.